Barely Significant
← all excerpts

FoxM1 is an independent poor prognostic marker and therapeutic target for advanced Middle Eastern breast cancer.

Oncotarget · 2018 · PMC5915129 · PMID 29707121

Europe PMCDOI
1
hedged sentence
0.1044
closest p · 2.1× alpha
0.1044
boldest claim

The sentences

did not reach statistical significancep = 0.1044not close (p > 0.1)
BC patients showing FoxM1 over-expression showed poor overall survival compared to cases not expressing this protein but this difference did not reach statistical significance ( p = 0.1044) (Table 1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.